Send to a Friend Share

Forest (FRX) Reports Successful Tender for Clinical Data (CLDA)

April 12, 2011 9:24 AM EDT
FRX Hot Sheet
Overall Analyst Rating:
    NEUTRAL (Down Down)

EPS Growth %: -30.4%
Forest Laboratories, Inc. (NYSE: FRX) unit, Magnolia Acquisition Corp., announces successful completion of the tender offer for all outstanding shares of common stock of, and certain outstanding notes and warrants convertible into or exercisable for the common stock of, Clinical Data, Inc. (Nasdaq: CLDA).

Magnolia intends to convert the entire principal amount of convertible notes it acquires in the tender offer into 6,110,599 shares of Clinical Data common stock and, if necessary to become the owner of more than 90% of the outstanding shares of common stock, to exercise its top-up option pursuant to the terms of the previously announced merger agreement among Forest, FL Holding CV, an indirect wholly-owned subsidiary of Forest, Magnolia and Clinical Data.


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Corporate News, Mergers and Acquisitions

Related Entities

Forest Laboratories/Clinical Data

Add Your Comment





Follow StreetInsider.com On Twitter